1. Home
  2. SABS vs RAY Comparison

SABS vs RAY Comparison

Compare SABS & RAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.80

Market Cap

336.6M

Sector

Health Care

ML Signal

HOLD

Logo Raytech Holding Limited Ordinary Shares

RAY

Raytech Holding Limited Ordinary Shares

N/A

Current Price

$2.76

Market Cap

15.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
SABS
RAY
Founded
2014
1993
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
336.6M
15.9M
IPO Year
2020
2022

Fundamental Metrics

Financial Performance
Metric
SABS
RAY
Price
$3.80
$2.76
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$10.75
N/A
AVG Volume (30 Days)
436.6K
5.2K
Earning Date
05-12-2026
07-24-2026
Dividend Yield
N/A
N/A
EPS Growth
78.53
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$5.84
Revenue Growth
N/A
N/A
52 Week Low
$1.85
$0.15
52 Week High
$5.15
$5.99

Technical Indicators

Market Signals
Indicator
SABS
RAY
Relative Strength Index (RSI) 54.08 49.67
Support Level $3.66 $2.39
Resistance Level $4.03 $3.15
Average True Range (ATR) 0.14 0.18
MACD 0.00 0.00
Stochastic Oscillator 52.50 69.49

Price Performance

Historical Comparison
SABS
RAY

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.

About RAY Raytech Holding Limited Ordinary Shares

Raytech Holding Ltd is principally engaged in product designing and manufacturing of various product ranges such as Hair Care, Mens Care and Womens Care products. It has sourced and wholesaled a wide range of personal care electrical appliances, which can be broadly classified into seven categories: hair styling series, including hair dryer, hair straightener and curling iron; trimmer series, including facial shaver, nose trimmer and eyebrow trimmer; eyelash curler; nail care series and other personal care appliances such as body and facial brush, reset brush, callus remover, sonic peeling, and others.

Share on Social Networks: